Skip to content

ASCELIA

AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY

 
  • En
  • Sv
  • About us
    • Management
    • Board of Directors
  • Therapeutic areas
    • Liver metastases
    • Gastric Cancer
  • Pipeline
    • Orviglance®
    • Oncoral
  • Partnering
  • Investors
    • Press releases
    • Financial reports
    • Presentations & articles
    • Events
    • Share information
    • Shareholders
    • Insiders
    • Equity research
    • Financial calendar
  • Governance
    • General Meeting
    • Articles of Association
    • Nomination Committee
    • Board of Directors
    • Audit Committee
    • Remuneration Committee
    • Commercialization Committee
    • Remuneration
    • Auditors
    • Internal control
  • Career
    • Open positions
    • Our values
  • Contact
18 events found.

Events

Events Search and Views Navigation

Event Views Navigation

  • List
Today
  • May 2021

  • Wed 12

    Interim Report Q1 2021 (January-March 2021)

    2021-05-12 @ 08:00 - 10:00

    Report will be released at 8.00am CET and conference call at 10:00am CET  

  • Wed 12

    Interim Report Q1 2021 (January-March 2021)

    2021-05-12 @ 08:00 - 10:00

    Report will be released at 8.00am CET and conference call at 10:00am CET  

  • Tue 25

    ABGSC Life Science Summit – Virtual Seminar

    2021-05-25 @ 09:30 - 10:00

    Magnus Corfitzen will present at ABGSC Life Science Summit

  • Tue 25

    ABGSC Life Science Summit – Virtual Seminar

    2021-05-25 @ 09:30 - 10:00

    Magnus Corfitzen will present at ABGSC Life Science Summit

  • Tue 25

    Imaging Event – Erik Penser Bank – 25 May 2021

    2021-05-25 @ 10:05 - 10:45

    Carl Bjartmar, Chief Medical Officer will present at the Imaging Event - Erick Penser Bank. To watch the presentation live connect directly to: https://youtu.be/Y1hnTJ7FHDs  

  • Tue 25

    Imaging Event – Erik Penser Bank – 25 May 2021

    2021-05-25 @ 10:05 - 10:45

    Carl Bjartmar, Chief Medical Officer will present at the Imaging Event - Erick Penser Bank. To watch the presentation live connect directly to: https://youtu.be/Y1hnTJ7FHDs  

  • June 2021

  • Wed 2

    Redeye Growth Day – 2 June 2021

    2021-06-02 @ 12:40 - 13:00

    Magnus Corfitzen will present at the Redeye Growth day. Registration link to the broadcast : https://www.lyyti.in/Redeye_GrowthDay_2021 Live broadcast and schedule: https://www.redeye.se/events/808637/redeye-growth-day-2021

  • Wed 2

    Redeye Growth Day – 2 June 2021

    2021-06-02 @ 12:40 - 13:00

    Magnus Corfitzen will present at the Redeye Growth day. Registration link to the broadcast : https://www.lyyti.in/Redeye_GrowthDay_2021 Live broadcast and schedule: https://www.redeye.se/events/808637/redeye-growth-day-2021

  • Wed 16

    Life Science Seminar with HC Andersen – 16 June 2021

    2021-06-16 @ 10:35 - 10:55

    Ascelia Pharma will present at the HC Andersen Life Science Seminar. To register: https://hcandersencapital643.clickmeeting.com/life-science-seminar/register

  • Wed 16

    Life Science Seminar with HC Andersen – 16 June 2021

    2021-06-16 @ 10:35 - 10:55

    Ascelia Pharma will present at the HC Andersen Life Science Seminar. To register: https://hcandersencapital643.clickmeeting.com/life-science-seminar/register

  • Tue 29

    LifeSci Nordic Biotech Summit – June 29, 2021

    2021-06-29 @ 17:30 - 18:00

    Ascelia Pharma will present at the LifeSci Nordic Biotech Summit. To register to the event: https://web.cvent.com/event/63ec6ced-8c45-4618-847d-e329242d3b59/summary

  • Tue 29

    LifeSci Nordic Biotech Summit – June 29, 2021

    2021-06-29 @ 17:30 - 18:00

    Ascelia Pharma will present at the LifeSci Nordic Biotech Summit. To register to the event: https://web.cvent.com/event/63ec6ced-8c45-4618-847d-e329242d3b59/summary

  • August 2021

  • Thu 19

    Half-year report 2021 (April-June 2021)

    2021-08-19 @ 08:00

    Report will be released at 8.00am and conference call at 10.00am CET

  • Thu 19

    Half-year report 2021 (April-June 2021)

    2021-08-19 @ 08:00

    Report will be released at 8.00am and conference call at 10.00am CET

  • Tue 24

    MVA Oncology Network Meeting – Development Of Orphan Drugs Within Oncology

    2021-08-24 @ 15:00 - 16:30

    Andreas Norlin, Project Director and Head of Non-clinical Development will participate at the MVA ONCOLOGY NETWORK MEETING. Andreas will share his knowledge: - Building an Orphan Oncology company: past experience […]

  • Tue 24

    MVA Oncology Network Meeting – Development Of Orphan Drugs Within Oncology

    2021-08-24 @ 15:00 - 16:30

    Andreas Norlin, Project Director and Head of Non-clinical Development will participate at the MVA ONCOLOGY NETWORK MEETING. Andreas will share his knowledge: - Building an Orphan Oncology company: past experience […]

  • September 2021

  • Wed 1

    Pareto Healthcare Conference – 1 September 2021 (Virtual)

    2021-09-01

    Ascelia Pharma will participate in this conference.

  • Wed 1

    Pareto Healthcare Conference – 1 September 2021 (Virtual)

    2021-09-01

    Ascelia Pharma will participate in this conference.

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
Learn more

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. […]
Learn more

Contact

If you wish to participate via webcast, please use the link below. You can ask written questions through the webcast: https://ir.financialhearings.com/ascelia-pharma-q1-report-2024
Learn more

Our values

Our values inspire our ambitions, decision making and collaboration to help us reach our highest potential. INTEGRITY We build powerful relationship with mutual respect and adhere to the high ethical […]
  1. Start (en)
  2. Calendar
  3. List

About us

  • Start (en)
  • About us
  • Career
  • Contact
  • Privacy policy
  • About cookies
  • Cookie settings
  • IMPORTANT INFORMATION

Pipeline

  • Oncoral
  • Orviglance®

IR & Media

  • Subscribe to press releases
  • Press releases & News
  • Financial Reports

Contact us

Ascelia Pharma AB
Hyllie Boulevard 34
215 32 Malmö
Sweden
Phone: +46 735 17 91 18

info@ascelia.com

Follow us

 

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (former working name Mangoral) and Oncoral – in clinical development.

Ascelia Pharma has global headquarters in Malmö, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE).

© Copyright 2021 - Ascelia Pharma AB | We use cookies to improve our services | Disclaimer Market data could be delayed. Delivered by Modular Finance.

Video
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
  • Necessary
    These cookies are not optional. They are needed for the website to function.
  • Statistics
    In order for us to improve the website's functionality and structure, based on how the website is used.
  • Experience
    In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
  • Marketing
    By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save Accept all